A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects
Clinical trial NCT03268083 · COMPLETED
Trial details
- NCT number
- NCT03268083
- Sponsor
- Enimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-08-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.